| Latest | F'cast | |
|---|---|---|
| Div Yield | 0.0% | 0.0% |
| Div Cover | n/a | n/a |
| Op Mrgn | -13.3% | n/a |
| ROCE | n/a |
| Latest | F'cast | |
|---|---|---|
| P/E | n/a | n/a |
| PEG | n/a | n/a |
| Pr/Revenue | 4.1 | n/a |
| Pr/Book | 7.6 |
| Latest | F'cast | |
|---|---|---|
| Revenue | 31.0% | n/a |
| PBT | n/a | n/a |
| EPS | n/a | n/a |
| DPS | n/a | n/a |
| Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Dec-21 | 142.80 | 19.88 | 22.77p | 54.0 | n/a | n/a | n/a | 0.0% |
| 31-Dec-22 | 139.99 | (45.98) | (41.29)p | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-23 | 89.54 | (188.53) | (163.11)p | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-24 | 128.80 | (47.26) | (41.75)p | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-25 | 168.74 | (31.94) | (26.92)p | n/a | n/a | n/a | n/a | 0.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
| Admission to Trading Application | 11-Aug-2026 | 09:12 | RNS |
| Half Year Trading Update and Notice of Results | 07-Aug-2026 | 07:00 | RNS |
| Total Voting Rights | 03-Aug-2026 | 07:00 | RNS |
| Should you buy shares in Oxford Biomedica? | 29-Jul-2026 | Times |
| Need to know: Opec cuts forecast ... Tesco cuts ... | 16-Aug-2008 | Times |
| Need to know | 10-May-2008 | Times |
No deals were found in the last 28 days.
| Currency | UK Pounds |
| Share Price | 492.50p |
| Change Today | 5.50p |
| % Change | 1.13 % |
| 52 Week High | 913.00 |
| 52 Week Low | 439.50 |
| Volume | 890,395 |
| Shares Issued | 121.04m |
| Market Cap | £596.14m |
| Beta | 0.03 |
| RiskGrade | 125 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| No dividends found |
| Time | Volume / Share Price |
| 15:38 | 177,584 @ 490.56p |
| 17:07 | 10,000 @ 492.50p |
| 16:35 | 1,362 @ 492.50p |
| 16:35 | 204,060 @ 492.50p |
| 16:35 | 571 @ 492.50p |
| Chair | Roch Doliveux |
| CEO | Frank Mathias |
| CFO | Lucinda (Lucy) Crabtree |
You are here: research